Health
Life-saving cancer drug a boon to patients in Japan, but price prompts debate
TOKYO (Kyodo) -- Nivolumab, an immune checkpoint inhibitor lauded for its groundbreaking approach to cancer treatment, marked its 10th anniversary thi Full article
-
Artificial heart made of iPS cells unveiled to press, to be displayed at 2025 Osaka expo
(2024/10/2)
-
Expert laments delays in dementia diagnosis in Japan
(2024/9/29)
-
It's time to roll up sleeves for new COVID, flu shots
(2024/9/26)
-
Japan researchers identify fat-burning proteins
(2024/9/23)
-
Want to burn calories? Climbing stairs might be the most effective exercise for you
(2024/9/22)
-
Japan pledges 3 mil. doses of mpox vaccine to WHO
(2024/9/17)
-
Midwife in Japan publishes picture book on sex education in response to parents' voices
(2024/9/16)
-
Japan, US scientists win Ig Nobel prize for study on anal breathing
(2024/9/13)
-
Protein quality, quantity both important as intake in Japan short of target: expert
(2024/9/8)
-
Over 10% of Japanese gained weight during COVID pandemic: health survey
(2024/8/31)
-
Sensors can read your sweat and predict overheating. Here's why privacy advocates care
(2024/8/25)
-
People warned to beware of tick-borne infections in Japan
(2024/8/21)
-
New 'natto' fermented soybean product packed with immune system-boosting bacteria
(2024/8/21)
-
Japan team develops COVID treatment using synthetic immune cells
(2024/8/16)
-
Kobayashi Pharma failed to report 11 deaths possibly linked to red yeast supplement
(2024/8/14)
-
118 pregnant, nursing women took own lives in 2022-23 in Japan: survey
(2024/8/8)
-
July ends 13-month streak of global heat records as El Nino ebbs, but experts warn against relief
(2024/8/8)
-
Developers hope Japan device letting men feel period pain will build empathy, openness
(2024/8/2)
-
Extreme heat is 'silent killer,' affecting 3 out of 4 workers in Asia-Pacific: ILO report
(2024/7/31)
-
Editorial: Vigilance needed as 11th COVID wave hits Japan
(2024/7/30)
Also in The Mainichi
- The Mainichi on social media
